Blood microRNA changes in depressed patients during antidepressant treatment

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482

KEGG: Kyoto Encyclopedia of Genes and Genomes

Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077

KEGG: Kyoto Encyclopedia of Genes and Genomes

Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001

Systematic determination of genetic network architecture

Tavazoie, S., Hughes, J. D., Campbell, M. J., Cho, R. J., & Church, G. M. (1999) · Nature Genetics · doi:10.1038/10343 · Cited by 2,509

Gene silencing by microRNAs: contributions of translational repression and mRNA decay

Huntzinger, E., & Izaurralde, E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2936 · Cited by 2,339

Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms

Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795

The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission

Popoli, M., Yan, Z., McEwen, B. S., & Sanacora, G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3138 · Cited by 1,393

Towards a glutamate hypothesis of depression

Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036

Characterization of microRNA expression profiles in normal human tissues.

Liang, Y., Ridzon, D., Wong, L., & Chen, C. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-166 · Cited by 881

Circulating hsa-let-7e-5p and hsa-miR-125a-5p as Possible Biomarkers in the Diagnosis of Major Depression and Bipolar Disorders

Gečys, D., Dambrauskienė, K., Šimonytė, S., Patamsytė, V., Vilkevičiūtė, A., Musneckis, A., Butkutė-Šliuožienė, K., Lesauskaitė, V., Žemaitis, L., Ūsaitė, D., et al. (2022) · Disease Markers · doi:10.1155/2022/3004338 · Cited by 35

Potential of Circulating miRNAs as Molecular Markers in Mood Disorders and Associated Suicidal Behavior

Roy, B., Ochi, S., & Dwivedi, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054664 · Cited by 37

Coding and Noncoding Gene Expression Biomarkers in Mood Disorders and Schizophrenia

Mamdani, F., Martin, M. V., Lencz, T., Rollins, B. L., Robinson, D. G., Moon, E. A., Malhotra, A. K., & Vawter, M. P. (2013) · Disease Markers · doi:10.1155/2013/748095 · Cited by 33

Microbial regulation of microRNA expression in the brain–gut axis

Moloney, G. M., Dinan, T. G., Clarke, G. A., & Cryan, J. F. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.08.005 · Cited by 32

MicroRNAs in Major Depressive Disorder

Fries, G. R., Zhang, W., Benevenuto, D., & Quevedo, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-05542-4_9 · Cited by 29

miRNAs in Drug Response Variability: Potential Utility as Biomarkers for Personalized Medicine

Latini, A., Borgiani, P., Novelli, G., & Ciccacci, C. (2019) · Pharmacogenomics · doi:10.2217/pgs-2019-0089 · Cited by 33

Benefits of animal models to understand the pathophysiology of depressive disorders

Czéh, B., & Simon, M. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110049 · Cited by 30

A study of differential microRNA expression profile in migraine: the microMIG exploratory study

Gallardo, V. J., Gómez‐Galván, J. B., Asskour, L., Torres‐Ferrús, M., Alpuente, A., Caronna, E., & Pozo‐Rosich, P. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01542-z · Cited by 31

MicroRNAs in Post-traumatic Stress Disorder

Snijders, C., de Nijs, L., Baker, D. G., Hauger, R. L., van den Hove, D., Kenis, G., Nievergelt, C. M., Boks, M. P., Vermetten, E. H. G. J. M., Gage, F. H., et al. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_32 · Cited by 31

Serum Exosomal miRNA-125b and miRNA-451a are Potential Diagnostic Biomarker for Alzheimer’s Diseases

Duan, X., Zheng, Q. Y., Liang, L., & Zhou, L. (2024) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s444567 · Cited by 29

Genetic variants in the promoters of let-7 family are associated with an increased risk of major depressive disorder

Liang, Y., Zhao, G., Sun, R., Mao, Y., Li, G., Chen, X., Gao, L., & Hu, Z. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.04.035 · Cited by 28

MicroRNA-34 Contributes to the Stress-related Behavior and Affects 5-HT Prefrontal/GABA Amygdalar System through Regulation of Corticotropin-releasing Factor Receptor 1

Andolina, D., Segni, M. D., Accoto, A., Iacono, L. L., Borreca, A., Ielpo, D., Berretta, N., Perlas, E., Puglisi‐Allegra, S., & Ventura, R. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0925-z · Cited by 29

Neutral sphingomyelinase 2 inhibition attenuates extracellular vesicle release and improves neurobehavioral deficits in murine HIV

Zhu, X., Hollinger, K. R., Huang, Y., Borjabad, A., Kim, B., Arab, T., Thomas, A. G., Moniruzzaman, M., Lovell, L. E., Turchinovich, A. A., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105734 · Cited by 28

Hippocampal microRNA-26a-3p deficit contributes to neuroinflammation and behavioral disorders via p38 MAPK signaling pathway in rats

Wang, C., Li, Y., Yi, Y., Liu, G., Guo, R., Wang, L., Lan, T., Wang, W., Chen, X., Chen, S., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02645-1 · Cited by 27

Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk

Srivastava, A., Singh, P., Gupta, H., Kaur, H., Kanojia, N., Guin, D., Sood, M., Chadda, R. K., Yadav, J., Vohora, D., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081993 · Cited by 26

Epigenetic Mechanisms of Rapid-Acting Antidepressants

Inserra, A., Campanale, A., Rezai, T., Romualdi, P., & Rubino, T. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03055-y · Cited by 27

MicroRNA 101b Is Downregulated in the Prefrontal Cortex of a Genetic Model of Depression and Targets the Glutamate Transporter SLC1A1 (EAAT3)in Vitro

Wei, Y. B., Melas, P. A., Villaescusa, J. C., Liu, J. J., Xu, N., Christiansen, S. H., Elbrønd-Bek, H., Woldbye, D. P. D., Wegener, G., Mathé, A. A., et al. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw069 · Cited by 25

Impact of Expression and Genetic Variation of microRNA-34b/c on Cognitive Dysfunction in Patients with Major Depressive Disorder

Sun, N., Yang, C., He, X., Liu, Z., Liu, S., Li, X., Wang, Y., Jin, R., & Zhang, K. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s247787 · Cited by 28

Alterations in circulating extracellular vesicles underlie social stress‐induced behaviors in mice

Sakamoto, S., Mallah, D., Medeiros, D., Dohi, E., Imai, T., Rose, I. V. L., Matoba, K., Zhu, X., Kamiya, A., & Kano, S. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13204 · Cited by 27

Heterogeneity in major depressive disorder: The need for biomarker-based personalized treatments

Suseelan, S., & Pinna, G. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.09.001 · Cited by 28

Social stress in adolescents induces depression and brain-region-specific modulation of the transcription factor MAX

Resende, L. S., Amaral, C. E., Soares, R. B., Alves, A. S., Alves-dos-Santos, L., Britto, L. R. G., & Chiavegatto, S. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.202 · Cited by 26

Peripheral Signatures of Psychiatric Disorders: MicroRNAs

Camkurt, M. A., Güneş, S., Coşkun, S., & Fındıklı, E. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.4.313 · Cited by 26

Downregulation of microRNA‑124‑3p suppresses the mTOR signaling pathway by targeting DDIT4 in males with major depressive disorder

Wang, Q., Zhao, G., Yang, Z., Liu, X., & Xie, P. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3235 · Cited by 26

A Perspective on the Role of microRNA-128 Regulation in Mental and Behavioral Disorders

Ching, A.-S., & Ahmad-Annuar, A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00465 · Cited by 24

Distance running alters peripheral microRNAs implicated in metabolism, fluid balance, and myosin regulation in a sex-specific manner

Hicks, S. D., Jacob, P., Middleton, F. A., Perez, O., & Gagnon, Z. E. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00035.2018 · Cited by 25

MicroRNA-34a Regulates the Depression-like Behavior in Mice by Modulating the Expression of Target Genes in the Dorsal Raphè

Iacono, L. L., Ielpo, D., Accoto, A., Segni, M. D., Babicola, L., D’Addario, S. L., Ferlazzo, F., Pascucci, T., Ventura, R., & Andolina, D. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01750-2 · Cited by 28

The Association between Depression and Gastroesophageal Reflux based on Phylogenetic Analysis of miRNA Biomarkers

Chen, Y., & Wang, H. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200425214906 · Cited by 25

Preliminary examination of microRNA expression profiling in bipolar disorder I patients during antipsychotic treatment

Lim, C. H., Zainal, N. Z., Kanagasundram, S., Zain, S. M., & Mohamed, Z. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32457 · Cited by 23

Drugs used to treat bipolar disorder act via microRNAs to regulate expression of genes involved in neurite outgrowth

Kidnapillai, S., Wade, B., Bortolasci, C. C., Panizzutti, B., Spolding, B., Connor, T., Crowley, T. M., Jamain, S., Gray, L. J., Leboyer, M., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119895534 · Cited by 24

Investigating the influence of perinatal nicotine and alcohol exposure on the genetic profiles of dopaminergic neurons in the VTA using miRNA–mRNA analysis

Kazemi, T., Huang, S., Avci, N. G., Waits, C. M. K., Akay, Y. M., & Akay, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-71875-1 · Cited by 25

Resilient Phenotype in Chronic Mild Stress Paradigm Is Associated with Altered Expression Levels of miR-18a-5p and Serotonin 5-HT1a Receptor in Dorsal Part of the Hippocampus

Żurawek, D., Gruca, P., Antkiewicz‐Michaluk, L., & Dziedzicka‐Wasylewska, M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1622-2 · Cited by 23

MiRNA‐199a‐5p targets WNT2 to regulate depression through the CREB/BDNF signaling in hippocampal neuron

Liu, Z., Yang, J., Fang, Q., Shao, H., Yang, D., Sun, J., & Gao, L. (2021) · Brain and Behavior · doi:10.1002/brb3.2107 · Cited by 22

Micro RNA s 29b and 181a down‐regulate the expression of the norepinephrine transporter and glucocorticoid receptors in PC 12 cells

Deng, M., Tufan, T., Raza, M. U., Jones, T. C., & Zhu, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13761 · Cited by 22

MicroRNA-Mediated Regulation of ITGB3 and CHL1 Is Implicated in SSRI Action

Oved, K., Farberov, L., Gilam, A., Israel‐Elgali, I., Haguel, D., Gurwitz, D., & Shomron, N. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00355 · Cited by 22

miRNAs as potential diagnostic biomarkers and pharmacogenomic indicators in psychiatric disorders

Tsermpini, E. E., Kalogirou, C., Kyriakopoulos, G. C., Patrinos, G. P., & Stathopoulos, C. (2022) · The Pharmacogenomics Journal · doi:10.1038/s41397-022-00283-7 · Cited by 22

Distribution of microRNAs associated with major depressive disorder among blood compartments

Homorogan, C., ENĂTESCU, V. R., Nițușcă, D., Marcu, A., Șeclăman, E. P., & Marian, C. (2021) · Journal of International Medical Research · doi:10.1177/03000605211006633 · Cited by 21

Uncovering the Roles of MicroRNAs in Major Depressive Disorder: From Candidate Diagnostic Biomarkers to Treatment Response Indicators

Homorogan, C., Nițușcă, D., Șeclăman, E. P., ENĂTESCU, V. R., & Marian, C. (2021) · Life · doi:10.3390/life11101073 · Cited by 19

A Whole Transcriptome Analysis in Peripheral Blood Suggests That Energy Metabolism and Inflammation Are Involved in Major Depressive Disorder

Wang, Y., Wei, J., Chen, T., Yang, X., Zhao, L., Wang, M., Dou, Y., Du, Y., Ni, R., Li, T., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.907034 · Cited by 21

Changes in Multiple microRNA Levels with Antidepressant Treatment Are Associated with Remission and Interact with Key Pathways: A Comprehensive microRNA Analysis

Funatsuki, T., Ogata, H., Tahara, H., Shimamoto, A., Takekita, Y., Koshikawa, Y., Nonen, S., Higasa, K., Kinoshita, T., & Kato, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512199 · Cited by 24

Endocannabinoid signaling and epigenetics modifications in the neurobiology of stress-related disorders

Coelho, A. A., Bastos, S., Gobira, P. H., & Lisboa, S. F. D. S. (2023) · Neuronal Signaling · doi:10.1042/ns20220034 · Cited by 22

Potential Molecular and Cellular Mechanism of Psychotropic Drugs

Seo, M. S., Scarr, E., Lai, C., & Dean, B. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.2.94 · Cited by 19

The role of circulating blood microRNA-374 and microRNA-10 levels in the pathogenesis and therapeutic mechanisms of major depressive disorder

Liu, W., Zhang, F., Zheng, Y., Shen, H., Zhang, T., Guo, Q., Xu, H. J., Chen, H., Liu, C., Yu, S., et al. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136184 · Cited by 17

Therapeutic treatment with fluoxetine using the chronic unpredictable stress model induces changes in neurotransmitters and circulating miRNAs in extracellular vesicles

Estévez-Cabrera, M. M., Sánchez‐Muñoz, F., Pérez‐Sánchez, G., Pavón, L., Hernández-Díazcouder, A., Cortes-Altamirano, J. L., Soria-Fregozo, C., Alfaro-Rodríguez, A., & Bonilla‐Jaime, H. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13442 · Cited by 18

Validation study of microRNAs previously associated with antidepressant response in older adults treated for late-life depression with venlafaxine

Marshe, V. S., Islam, F., Maciukiewicz, M., Fiori, L. M., Yerko, V., Yang, J., Turecki, G., Foster, J. A., Kennedy, S. H., Blumberger, D. M., et al. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109867 · Cited by 19

Clinical Insights into MicroRNAs in Depression: Bridging Molecular Discoveries and Therapeutic Potential

Kaurani, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052866 · Cited by 20

Noncoding RNAs in Depression

Lin, R., & Turecki, G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_11 · Cited by 17

Changes in Non-Coding RNA in Depression and Bipolar Disorder: Can They Be Used as Diagnostic or Theranostic Biomarkers?

Gibbons, A. S., Sundram, S., & Dean, B. (2020) · Non-Coding RNA · doi:10.3390/ncrna6030033 · Cited by 17

MicroRNAs, Stem Cells in Bipolar Disorder, and Lithium Therapeutic Approach

Coradduzza, D., Garroni, G., Congiargiu, A., Balzano, F., Cruciani, S., Sedda, S., Nivoli, A., & Maioli, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810489 · Cited by 19

Ferroptosis-related genes as diagnostic markers for major depressive disorder and their correlations with immune infiltration

Chen, J., Jiang, X., Gao, X., Wu, W., Gu, Z., Yin, G., Sun, R., Li, J., Wang, R., Zhang, H., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1215180 · Cited by 17

Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder

Umehara, H., Numata, S., Tajima, A., Nishi, A., Nakataki, M., Imoto, I., Sumitani, S., & Ohmori, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157232 · Cited by 18

MicroRNA-382-5p Targets Nuclear Receptor Subfamily 3 Group C Member 1 to Regulate Depressive-Like Behaviors Induced by Chronic Unpredictable Mild Stress in Rats

Li, S., Ma, H., Yuan, X., Zhou, X., Wan, Y., & Chen, S. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s243920 · Cited by 17

A Role for mir-26a in Stress: A Potential sEV Biomarker and Modulator of Excitatory Neurotransmission

Lafourcade, C., Fernández, A., Ramírez, J. P., Corvalán, K., Carrasco, M., Iturriaga, A., Bátiz, L. F., Luarte, A., & Wyneken, Ú. (2020) · Cells · doi:10.3390/cells9061364 · Cited by 17

Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review

Pisanu, C., Severino, G., Toma, I. D., Dierssen, M., Fusar‐Poli, P., Gennarelli, M., Lió, P., Maffioletti, E., Maron, E., Mehta, D., et al. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.12.005 · Cited by 15

Examining redox modulation pathways in the post-mortem frontal cortex in patients with bipolar disorder through data mining of microRNA expression datasets

Kim, H. K., Tyryshkin, K., Elmi, N., Feilotter, H. E., & Andreazza, A. C. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.01.011 · Cited by 15

miR-132 and miR-942 Expression Levels in Children with Attention Deficit and Hyperactivity Disorder: A Controlled Study

Coşkun, Ş., Karadağ, M., Gökçen, C., & Öztuzcu, S. (2021) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2021.19.2.262 · Cited by 14

Plasma miRNAs as potential biomarkers for schizophrenia in a Jordanian cohort

Shboul, M., Domi, A. B., Zahra, A., Khasawneh, A. G., & Darweesh, R. F. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.01.018 · Cited by 14

MicroRNA-34a regulates 5-HT2C expression in dorsal raphe and contributes to the anti-depressant-like effect of fluoxetine

Iacono, L. L., Ielpo, D., Parisi, C., Napoli, G., Accoto, A., Segni, M. D., Babicola, L., D’Addario, S. L., Guzzo, S. M., Pascucci, T., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108559 · Cited by 15

Restraint Stress in Mice Alters Set of 25 miRNAs Which Regulate Stress- and Depression-Related mRNAs

Solich, J., Kuśmider, M., Faron-Górecka, A., Pabian, P., & Dziedzicka-Wasylewska, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249469 · Cited by 13

Transcriptomic signatures of treatment response to the combination of escitalopram and memantine or placebo in late-life depression

Grzenda, A. L., Siddarth, P., Laird, K. T., Yeargin, J., & Lavretsky, H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0752-2 · Cited by 13

Effect of citalopram and sertraline on the expression of miRNA- 124, 132, and 16 and their protein targets in patients with depression.

Ahmadimanesh, M., Etemad, L., Rad, D. M., Ghahremani, M. H., Mohammadpour, A. H., Esfehani, R. J., Jowsey, P. A., Behdani, F., Moallem, S. A., & Abbaszadegan, M. R. (2023) · PubMed Central · doi:10.22038/ijbms.2023.66496.14595 · Cited by 12

RNA ‐sequencing profiles hippocampal gene expression in a validated model of cancer‐induced depression

Nashed, M. G., Linher‐Melville, K., Frey, B. N., & Singh, G. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12323 · Cited by 13

miRNA Mechanisms Underlying the Association of Beta Blocker Use and Bone Mineral Density

Nevola, K. T., Kiel, D. P., Zullo, A. R., Weiß, S., Homuth, G., Foessl, I., Obermayer-Pietsch, B. M., Motyl, K. J., & Lary, C. W. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4160 · Cited by 13

Differential expression of serum extracellular vesicle microRNAs and analysis of target-gene pathways in major depressive disorder

Cuomo-Haymour, N., Kaiser, S., Hartmann-Riemer, M. N., Guetter, K., Klaus, F., Cathomas, F., Seifritz, E., Bergamini, G., Russo, G., & Pryce, C. R. (2022) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2022.100049 · Cited by 16

The potential of microRNAs as putative biomarkers in major depressive disorder and suicidal behavior

Serafini, G., Trabucco, A., Corsini, G. P., Escelsior, A., Amerio, A., Aguglia, A., Nasrallah, H. A., & Amore, M. (2021) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2021.100035 · Cited by 14

Circulating miRNAs as Potential Biomarkers for Patient Stratification in Bipolar Disorder: A Combined Review and Data Mining Approach

Clausen, A. R., Durand, S., Petersen, R. L., Staunstrup, N. H., & Qvist, P. (2022) · Genes · doi:10.3390/genes13061038 · Cited by 14

Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes

Maffioletti, E., Salvi, A., Conde, I., Maj, C., Gennarelli, M., Petro, G. D., & Bocchio‐Chiavetto, L. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.10.005 · Cited by 14

Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patients

Delacrétaz, A., Glatard, A., Dubath, C., Gholam‐Rezaee, M., Sanchez-Mut, J. V., Gräff, J., von Gunten, A., Conus, P., & Eap, C. B. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0792-0 · Cited by 12

A preliminary analysis of association between plasma microRNA expression alteration and symptomatology improvement in Major Depressive Disorder (MDD) patients before and after antidepressant treatment

Zhang, Q., Lu, J. Z., Sun, X., Guo, W., Zhao, L., Fan, H., Zhong, A., Wei, N., Dai, Y.-H., Zhang, L.-Y., et al. (2014) · The European Journal of Psychiatry · doi:10.4321/s0213-61632014000400006 · Cited by 12

Genetic Biomarkers in Alzheimer’s Disease

Khan, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804832-0.00004-3 · Cited by 13

Modulation of neuroplasticity and neuroinflammation by exosomal proteins and microRNA in depression: A review

Daksh, R., Sharma, P., Khanna, S., Mudgal, J., Hariharapura, R. C., & Nampoothiri, M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142829 · Cited by 11

RNA Biomarkers in Bipolar Disorder and Response to Mood Stabilizers

Pisanu, C., & Squassina, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210067 · Cited by 13

The interaction of miR-34b/c polymorphisms and negative life events increases susceptibility to major depressive disorder in Han Chinese population

Xu, C., Yang, C., Zhang, A., Xu, Y. J., Li, X., Liu, Z., Liu, S., Sun, N., & Zhang, K. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.04.061 · Cited by 11

Mental Health Epigenetics: A Primer With Implications for Counselors

Jones, D. E., Park, J. S., Gamby, K., Bigelow, T. M., Baye, T. M., & Folger, A. T. (2021) · The Professional Counselor · doi:10.15241/dej.11.1.102 · Cited by 12

MicroRNAs as Diagnostic Biomarkers and Predictors of Antidepressant Response in Major Depressive Disorder: A Systematic Review

Carneiro, B. A., Guerreiro‐Costa, L. N. F., Lins-Silva, D. H., Guimaraes, D. F., Souza, L. S., Leal, G. C.-G., Caliman‐Fontes, A. T., Beanes, G., Costa, R. D. S., & Quarantini, L. C. (2024) · Cureus · doi:10.7759/cureus.56910 · Cited by 11

Increased Levels of miR-30e, miR-132, miR-185, and miR- 212 at Baseline and Increased Brain-derived Neurotrophic Factor Protein and mRNA Levels after Treatment in Patients with Major Depressive Disorder

Lin, C. C., Lee, C. T., Sun, M. H., & Huang, T. L. (2017) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000297 · Cited by 11

Methylation analysis for postpartum depression: a case control study

Nakamura, Y., Nakatochi, M., Kunimoto, S., Okada, T., Aleksić, B., Toyama, M., Shiino, T., Morikawa, M., Yamauchi, A., Yoshimi, A., et al. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2172-x · Cited by 12

MicroRNAs: fundamental regulators of gene expression in major affective disorders and suicidal behavior?

Serafini, G., Pompili, M., Hansen, K. F., Obrietan, K. H., Dwivedi, Y., Amore, M., Shomron, N., & Girardi, P. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00208 · Cited by 10

Evaluating the Connection between MicroRNAs and Long Non-Coding RNAs for the Establishment of the Major Depressive Disorder Diagnosis

Prodan-Bărbulescu, C., Șeclăman, E. P., ENĂTESCU, V. R., Faur, F. I., Ghenciu, L. A., Tuţac, P., Pașca, P., & Grigoriță, L. O. (2024) · Biomedicines · doi:10.3390/biomedicines12030516 · Cited by 8

Neurobehavioral Alterations in a Genetic Murine Model of Feingold Syndrome 2

Fiori, E., Babicola, L., Andolina, D., Coassin, A., Pascucci, T., Patella, L., Han, Y.-C., Ventura, A., & Ventura, R. (2015) · Behavior Genetics · doi:10.1007/s10519-015-9724-8 · Cited by 9

Psychological stress disturbs bone metabolism via miR-335-3p/Fos signaling in osteoclastPreprint

Zhang, J., Li, J., Huang, J., Xiang, X., Li, R., Zhai, Y., Lin, S., & Liu, W. (2024) · eLife · doi:10.7554/elife.95944 · Cited by 8

MicroRNAs as Potential Biomarkers for Exercise-Based Cancer Rehabilitation in Cancer Survivors

Jiang, Y., Ghias, K., Gupta, S., & Gupta, A. (2021) · Life · doi:10.3390/life11121439 · Cited by 7

miRNAs in Major Depression: Possible Association of miR-17 and miR-92 with Childhood Traumas

Mert, A., Yücens, B., Karagür, E. R., Akça, H., Tümkaya, S., & Ateşçi, F. Ç. (2024) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.24.1218 · Cited by 6

MicroRNA-128–3p as a promising target in neuropsychiatric disorders: From epigenetics to pharmacological intervention

Verma, A. K., Funahashi, Y., Roy, B., & Dwivedi, Y. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118452 · Cited by 9

miR-26a is a Key Therapeutic Target with Enormous Potential in the Diagnosis and Prognosis of Human Disease

Guan, W., Chen, Y., & Fan, Y. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673271808231116075056 · Cited by 6

The long-lasting effects of early life adversities are sex dependent: The signature of miR-34a

D’Addario, S. L., Municchi, D., Mancini, C., Ielpo, D., Babicola, L., Segni, M. D., Iacono, L. L., Ferlazzo, F., Cifani, C., Andolina, D., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.11.035 · Cited by 5

Electroconvulsive Stimulation in Rats Induces Alterations in the Hippocampal miRNome: Translational Implications for Depression

Ryan, K. M., Smyth, P. C., Blackshields, G., Kranaster, L., Sartorius, A., Sheils, O. M., & McLoughlin, D. M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03131-8 · Cited by 5

Molecular biomarkers in depression: Toward personalized psychiatric treatment

Gururajan, A., Cryan, J. F., & Dinan, T. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813176-3.00026-2 · Cited by 5

The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry

Montel Hayes, R., Mason, C. E., & Miller, J. J. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1671122 · Cited by 5

Deciphering the role of miRNA-134 in the pathophysiology of depression: A comprehensive review

Wang, Y., Huang, Y., Luo, X., Lai, X., Yu, L., Zhao, Z., Zhang, A., Li, H., Huang, G., Li, Y., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39026 · Cited by 4

Pharmacogenetic and microRNA mechanisms of beta blocker use on bone

Lary, C. W., Atkinson, E. J., Spillane, J., Nayema, Z., Roy, T., Peters, R., Scott, G. T., Chen, H., Nagarajan, A., Brown, A., et al. (2024) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjae200 · Cited by 4

MicroRNAs: A Novel Approach for Monitoring Treatment Response in Major Depressive Disorder?

Cătană, C.-S., Marta, M. M., Ungureanu, D., & Crișan, C. (2025) · Non-Coding RNA · doi:10.3390/ncrna11020021 · Cited by 4

Signaling molecules and disturbances of cognitive functions in brain diseases

Гомазков, О. А. (2015) · Neurochemical Journal · doi:10.1134/s1819712415020063 · Cited by 3

Berberine ameliorates chronic unpredictable mild stress induced depression like behaviors and elevating kelch-like erythroid cell-derived protein with CNC homology-associated protein 1-nuclear factor (erythroid-derived 2)-like 2 antioxidant signaling pathways

Deng, Z., Gao, W., Liu, X., Hu, J. X., Deng, P., & Chi, L. (2018) · Pharmacognosy Magazine · doi:10.4103/pm.pm_181_17 · Cited by 3

Pharmacogenomic Effects of β-Blocker Use on Femoral Neck Bone Mineral Density

Nevola, K. T., Nagarajan, A., Hinton, A. C., Trajanoska, K., Formosa, M. M., Xuereb‐Anastasi, A., van der Velde, N., Stricker, B. H. C., Rivadeneira, F., Fuggle, N. R., et al. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab092 · Cited by 3

Targeting epigenetics as future treatments of trauma- and stress-or-related disorders. Epidrugs and epinutraceuticals

Naidoo, V., Martínez-Iglesias, O. A., & Cacabelos, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823039-8.00012-5 · Cited by 3

Epigenetic biomarkers in neuropsychiatric disorders

Lin, C.-C., & Huang, T. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800226-1.00003-4 · Cited by 4

Functional Categorization of Disease Genes Based on Spectral Graph Theory and Integrated Biological Knowledge

Sreeja, A., Krishnakumar, U., & Vinayan, K. P. (2018) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-017-0279-7 · Cited by 3

Evaluation of serum MicroRNA expression profiles in patients with panic disorder

Çökmüş, F. P., Özmen, E., Alkın, T., Batır, M. B., & Çam, F. S. (2018) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2018.1429844 · Cited by 3

Mapping of Nervous System Diseases via MicroRNAs

(2016) · CRC Press eBooks · doi:10.1201/b19229 · Cited by 3

Plasma micro-RNA profiles in patients with major depressive disorder (MDD)

ENĂTESCU, V. R., Papavă, I., Enătescu, I., Antonescu, M., Anghel, A., Șeclăman, E. P., Sîrbu, I. O., Romosan, R. S., & Marian, C. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2016.01.393

Circulating Plasma Micro RNAs in Patients with Major Depressive Disorder Treated with Antidepressants: A Pilot Study

ENĂTESCU, V. R., Papavă, I., Enătescu, I., Antonescu, M., Anghel, A., Șeclăman, E. P., Sîrbu, I. O., & Marian, C. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.5.549 · Cited by 74

MicroRNA as therapeutic targets for treatment of depression

Obrietan, K. H., & Hansen, K. F. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s34811 · Cited by 55

MicroRNA-specific targets for neuronal plasticity, neurotransmitters, neurotrophic factors, and gut microbes in the pathogenesis and therapeutics of depression

Chen, C.-Y., Wang, Y., Lei, L., & Zhang, Y. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111186 · Cited by 14

Changes in Multiple microRNA Levels with Antidepressant Treatment Are Associated with Remission and Interact with Key Pathways: A Comprehensive microRNA Analysis

Funatsuki, T., Ogata, H., Tahara, H., Shimamoto, A., Takekita, Y., Koshikawa, Y., Nonen, S., Higasa, K., Kinoshita, T., & Kato, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512199 · Cited by 24